Alodokter has raised additional funding from existing investor MDI Ventures and new investor Samsung Ventures Investment Corporation (Samsung Ventures). Alodokter will use the funding to continually expand and digitize the healthcare ecosystem as well as develop new products for Alodokter’s platform. We look forward to Alodokter continuing strong traction in providing accessible, affordable, and trusted healthcare for all Indonesians!

Heritas first invested in Alodoktor Series C round in 2019 alongside investors Sequis Life, Philips, Hera Capital, Softbank Ventures Asia and Golden Gate Ventures. In 2020, Heritas continued its support for the company as it participated in the Series C extended round alongside MDI Ventures.

Read more about Alodoktor’s press release here.